Medios AG (OTCMKTS:MEDOF) Sees Significant Decline in Short Interest

Medios AG (OTCMKTS:MEDOF) was the target of a significant decrease in short interest in May. As of May 29th, there was short interest totaling 694 shares, a decrease of 63.9% from the May 14th total of 1,924 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

Medios Stock Performance

Shares of MEDOF stock remained flat at C$13.64 during trading hours on Friday. The stock has a fifty day simple moving average of C$13.64 and a two-hundred day simple moving average of C$13.64. Medios has a twelve month low of C$13.64 and a twelve month high of C$13.64.

Medios Company Profile

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, parenteral nutrition solutions, and investigational medicinal products.